Assent Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.37 Cr
as on 17-11-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.34 Cr
as on 17-11-2024
- Revenue 32.07%
(FY 2023)
- Profit -177706.27%
(FY 2023)
- Ebitda -2784.23%
(FY 2023)
- Net Worth -9.57%
(FY 2023)
- Total Assets -9.98%
(FY 2023)
About Assent Chemicals
The Corporate was formerly known as Satyanarayan Traders Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.37 Cr.
The company has closed loans amounting to ₹3.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dwarka Agarwal, Pushpa Agarwal, and Virendar Agarwal serve as directors at the Company.
- CIN/LLPIN
U24117AS1997PLC005065
- Company No.
005065
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 May 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Assent Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dwarka Agarwal  | Managing Director | 12-May-1997 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Virendar Agarwal | Director | 01-Jun-2010 | Current |
| Pushpa Agarwal | Whole-Time Director | 12-May-1997 | Current |
Financial Performance of Assent Chemicals.
Assent Chemicals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.07% increase. The company also saw a substantial fall in profitability, with a 177706.27% decrease in profit. The company's net worth dipped by a decrease of 9.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assent Chemicals?
In 2023, Assent Chemicals had a promoter holding of 97.26% and a public holding of 2.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarma Paints Manufacturing Private LimitedActive 13 years 10 monthsPushpa Agarwal and Virendar Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2018 | ₹3.00 M | Satisfied |
Icici Bank Limited Creation Date: 25 Aug 2015 | ₹3.69 M | Satisfied |
Icici Bank Limited Creation Date: 07 Nov 2014 | ₹3.20 M | Satisfied |
How Many Employees Work at Assent Chemicals?
Unlock and access historical data on people associated with Assent Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assent Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assent Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
